ATE116296T1 - Säureadditionssalze einer optisch aktiven alaninanilidverbindung und diese enthaltende, pharmazeutische zusammensetzungen. - Google Patents

Säureadditionssalze einer optisch aktiven alaninanilidverbindung und diese enthaltende, pharmazeutische zusammensetzungen.

Info

Publication number
ATE116296T1
ATE116296T1 AT91307249T AT91307249T ATE116296T1 AT E116296 T1 ATE116296 T1 AT E116296T1 AT 91307249 T AT91307249 T AT 91307249T AT 91307249 T AT91307249 T AT 91307249T AT E116296 T1 ATE116296 T1 AT E116296T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
acid addition
optically active
compositions containing
addition salts
Prior art date
Application number
AT91307249T
Other languages
English (en)
Inventor
Tetsuhide Kamijo
Toshiaki Yamaguchi
Mokko
Kazuhiko Ikegami
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Application granted granted Critical
Publication of ATE116296T1 publication Critical patent/ATE116296T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/255—Tartaric acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT91307249T 1990-08-08 1991-08-07 Säureadditionssalze einer optisch aktiven alaninanilidverbindung und diese enthaltende, pharmazeutische zusammensetzungen. ATE116296T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2211208A JP2514855B2 (ja) 1990-08-08 1990-08-08 光学活性なアラニンアニリド誘導体の酸付加塩

Publications (1)

Publication Number Publication Date
ATE116296T1 true ATE116296T1 (de) 1995-01-15

Family

ID=16602123

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91307249T ATE116296T1 (de) 1990-08-08 1991-08-07 Säureadditionssalze einer optisch aktiven alaninanilidverbindung und diese enthaltende, pharmazeutische zusammensetzungen.

Country Status (12)

Country Link
EP (1) EP0472325B1 (de)
JP (1) JP2514855B2 (de)
KR (1) KR100192531B1 (de)
AT (1) ATE116296T1 (de)
AU (1) AU646276B2 (de)
CA (1) CA2048714A1 (de)
DE (1) DE69106276T2 (de)
DK (1) DK143991A (de)
ES (1) ES2066363T3 (de)
FI (1) FI101700B1 (de)
HU (1) HU213210B (de)
NO (1) NO913004D0 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9320273D0 (en) * 1993-04-01 1993-11-17 Fisons Corp Compound useful in therapy
ZA942140B (en) * 1993-04-01 1994-10-03 Fisons Corp Salt of (S)-alpha-phenyl-2-pyridineethanamine useful in therapy
CA2748235A1 (en) 2008-12-24 2010-07-01 Astrazeneca Ab Ethanamine compounds and their use for treating depression

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE786875A (fr) * 1971-07-28 1973-01-29 Astra Pharma Prod Amide, methode pour sa preparation et ses compositions therapeutiques
US4696930A (en) * 1985-04-12 1987-09-29 Hoffmann-La Roche Inc. N-(heteroarylalkyl)acylanilide derivatives as antiarrhythmic agents
JPS6452797A (en) * 1987-01-06 1989-02-28 Takeda Chemical Industries Ltd Production of crystalline trh-tartrate

Also Published As

Publication number Publication date
KR100192531B1 (ko) 1999-06-15
JP2514855B2 (ja) 1996-07-10
ES2066363T3 (es) 1995-03-01
HUT58292A (en) 1992-02-28
DK143991A (da) 1992-02-09
FI101700B (fi) 1998-08-14
AU8145891A (en) 1992-02-13
NO913004D0 (no) 1991-08-01
DK143991D0 (da) 1991-08-07
JPH0495072A (ja) 1992-03-27
AU646276B2 (en) 1994-02-17
EP0472325A2 (de) 1992-02-26
FI913774A0 (fi) 1991-08-08
FI101700B1 (fi) 1998-08-14
HU213210B (en) 1997-03-28
CA2048714A1 (en) 1992-02-09
DE69106276T2 (de) 1995-05-18
HU912640D0 (en) 1992-01-28
KR920004334A (ko) 1992-03-27
HK1003787A1 (en) 1998-11-06
DE69106276D1 (de) 1995-02-09
EP0472325A3 (de) 1992-03-04
FI913774L (fi) 1992-02-09
EP0472325B1 (de) 1994-12-28

Similar Documents

Publication Publication Date Title
DK338187A (da) 13beta-milbemycinderivater samt deres fremstillingog anvendelse
FI891980A0 (fi) Menetelmä terapeuttisesti aktiivisten N1-(1,2-cis-2-halogeenisyklopropyyli)substituoitujen pyridonikarboksyylihappojohdannaisten valmistamiseksi
DE68917485D1 (de) Pyridazinon-Derivate und diese enthaltende pharmazeutische Zubereitungen.
DE68909548D1 (de) Organische hydrazin-verbindungen fuer pharmazeutische anwendung.
EP0689837A3 (de) Antihyperglykämisch wirksame Arzneimittel
ATE116296T1 (de) Säureadditionssalze einer optisch aktiven alaninanilidverbindung und diese enthaltende, pharmazeutische zusammensetzungen.
NO158622C (no) Analogifremgangsmaate for fremstilling av benzosyrederivater med antimikrobiell aktivitet.
ATE27270T1 (de) Thioester von acetylsalicylsaeure, ein verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ES543345A0 (es) Procedimiento para la obtencion de nuevos derivados de la piperidina
ATE57928T1 (de) 1-alkyl-ergolinyl-thioharnstoffderivate.
DE3887611D1 (de) Butensäure-Amide, deren Salze, diese enthaltende pharmazeutische Zusammensetzungen und Verfahren zu deren Herstellung.
ES8800144A1 (es) Procedimiento de obtencion de un tioester de la n-acetilcisteina y de sus sales de interes terapeutico
ATE109454T1 (de) Catecholaminester.
AU572374B2 (en) Azolyl-aroxymethyl-dimethylpentinols, their use as fungicides
TH13345A (th) อนุพันธ์กรดฟินิลแอซิติกที่ถูกแทนที่เชิงเฮทเทอโรไซคลิก กระบวนการสำหรับการเตรียมสารและการนำไปใช้ในยา

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee